Dr. Orrin Devinsky, MD

Dr. Devinsky practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Devinsky's NPI, 1679581623, was assigned on August 4, 2006. Dr. Devinsky graduated from Harvard Medical School in 1982. Dr. Devinsky holds New York license 154530.

Dr. Devinsky's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Devinsky's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Devinsky is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Devinsky to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Devinsky practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Devinsky's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Devinsky's licenses on file in 2 states: New York and New Jersey.

CMS data shows 48 Medicare services from Dr. Devinsky across 2 procedure codes in 2024, for 30 Medicare patients. Medicare paid $3,245 for them. Every service was in an office.

CMS counts 30 Medicare patients who saw Dr. Devinsky in 2024. The largest group is 65 to 74, with 11 patients. 70% of them have high cholesterol, and 60% have high blood pressure. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Devinsky's median patient age at 21, with 45% women.

In 2024, Dr. Devinsky wrote 192 Medicare Part D claims for 32 patients. 65% of them were for generic drugs. CMS names the drug for 55 of them, across 4 drugs with 11 or more claims each, at $20,730 in total drug cost. In 2023, CMS named 611 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Devinsky for performance year 2024, reported as part of a group. Dr. Devinsky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Devinsky as offering telehealth.

Dmand AI links 469 papers to Dr. Devinsky, published from 2008 to 2025. 2024 was the busiest year, with 43. The most frequent topics are Epilepsy, Seizures and Anticonvulsants. Dr. Devinsky has published most often in Epilepsia. Dr. Devinsky's most frequent co-authors are Werner K. Doyle, MD, Patricia Cristine Dugan, MD and Ruben Itamar Kuzniecky, MD.

Dmand AI links Dr. Devinsky to 8 clinical trials, 4 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Epilepsies, Myoclonic, Epilepsy and Lennox Gastaut Syndrome. NYU Langone Health sponsors the most, 4.

CMS Open Payments shows 46 general payments to Dr. Devinsky from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 86% of the total. UCB, Inc. paid the most, $26,136.

Dr. Devinsky graduated from Harvard Medical School in 1982.